Global healthcare leader Johnson & Johnson (J&J) commenced the J.P. Morgan Healthcare Conference by announcing its intent to acquire Intra-Cellular... Read more
Johnson & Johnson Expands Neuroscience Portfolio with $14.6 Billion Acquisition
06/12/2025
Published by vivi


